Hi there,

With lies and disinformation flooding the media landscape, and the Trump administration increasing its attacks on journalists, the need for independent news questioning and challenging those in power is more critical now than ever. We do not take any government or corporate funding, so we can remain unwavering in our commitment to bring you fearless trustworthy reporting on the issues that matter most. If our journalism is important to you, please donate today. Every dollar makes a difference. Thank you so much.

Democracy Now!

Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Watchdog Groups Criticize Tauzin’s New Lobbying Job

HeadlineDec 17, 2004

In news from Capitol Hill, Public Citizen is criticizing retiring Congressman Billy Tauzin for taking a $2 million post to head the country’s largest pharmaceutical lobbying firm. The watchdog group said the hiring indicated Washington’s revolving door between Capitol Hill and the lobbying world has spun out of control. Meanwhile Center for Responsive Politics reports the pharmaceutical industry donated more than $200,000 to Tauzin’s campaigns over the past 15 years.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top